4th Quarter - Report

BROWN RUDNICK LLP for APOTEX CORPORATION

Period 4th Quarter 2015 Filed Jan 15, 2016 Signed by Henry W. Menn III

Official filing
Firm
BROWN RUDNICK LLP
Client
APOTEX CORPORATION
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6 - The 21st Century Cures Act; Senate Innovations for Healthier Americans; Federal policy relating to GDUFA implementation and pricing of pharmaceuticals

LobbyistCovered position, as disclosed
ROBERT DENNIS FOREMAN New The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 to 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 to 2005)
LISA LAYMAN SPA, Sen. Stabenow (05-07); SPA, Sen Graham(01-04); LA, Sen Bryan(00); LA, Sen Chafee(97-99); CBO, PA(92-96)
HENRY W MENN CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Copyright/Patent/Trademark CPT

S. 1137-Protecting American Talent and Entrepreneurship Act of 2015; H.R. 9 - The Innovation Act

LobbyistCovered position, as disclosed
ROBERT DENNIS FOREMAN The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th), S. 1137 (114th)

Medicare/Medicaid MMM

Public Law No: 114-74 relating to generic drug Medicaid inflation rebate

LobbyistCovered position, as disclosed
ROBERT DENNIS FOREMAN The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Federal policy relating to federal procurement country of origin requirements for pharmaceuticals

LobbyistCovered position, as disclosed
ROBERT DENNIS FOREMAN The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.